nomifensine has been researched along with Depression, Endogenous in 83 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There were more withdrawals and dosage changes with nomifensine than with mianserin." | 6.66 | Depression and anxiety: mianserin and nomifensine compared in a double-blind multicentre trial. ( Boscredon, J; Escande, M; Girard, M; Granier, F; Oules, J; Schmitt, L, 1985) |
| "Nomifensine was introduced as an effective antidepressant drug with few side effects." | 5.26 | Drug fever due to nomifensine treatment in patients with endogenous depression. ( Lund, NO; Nielsen, JL, 1981) |
| "Nomifensine was compared to imipramine in treatment of 40 patients with endogenous major depressive disorder." | 5.06 | [A double-blind comparison study of nomifensine and imipramine in treating depressed patients]. ( Wang, XJ, 1989) |
| "Forty-two patients with depression and epilepsy were entered into an antidepressant trial of amitriptyline, nomifensine and placebo." | 5.05 | The treatment of depression in patients with epilepsy. A double-blind trial. ( Robertson, MM; Trimble, MR, 1985) |
| " In "endogenous" depression, a statistically significant linear dose-response relationship was found in all the efficacy variables assessed." | 2.66 | Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients. ( Delini-Stula, A; Heath, WR; Schiwy, W, 1989) |
| " There were more withdrawals and dosage changes with nomifensine than with mianserin." | 2.66 | Depression and anxiety: mianserin and nomifensine compared in a double-blind multicentre trial. ( Boscredon, J; Escande, M; Girard, M; Granier, F; Oules, J; Schmitt, L, 1985) |
| "There was no tendency to physical drug dependence during treatment and during a one-week placebo phase after discontinuation of Psyton." | 2.65 | [Long-term treatment of depressive syndromes with Psyton (author's transl)]. ( Jellinger, K; Koeppen, D; Rössner, M, 1982) |
| "The imipramine treated group were significantly older." | 2.65 | Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine. ( Montgomery, DB; Montgomery, SA; Robinson, C; Roy, D; Wynne-Willson, S, 1983) |
| " The dosage was 150 mg daily in both treatment groups." | 2.65 | Nomifensine and amitriptyline in the treatment of depression. A multi-centre double-blind comparison. ( Agren, H; Bjaring, B; Källström, B; Lund, M; Månsby, J; Peterson, LE; Roos, BE; Wistedt, B, 1983) |
| " Nomifensine thus appeared safe and superior to placebo on several key measures of depressive symptomatology in this multicenter study of depressed outpatients." | 2.65 | Double-blind placebo-controlled multicenter evaluation of the efficacy and safety of nomifensine in depressed outpatients. ( Brauzer, B; Charalampous, KD; Goldstein, BJ; Kentsmith, D; Rosenthal, S, 1984) |
| "Nomifensine was at least as effective as imipramine in reducing depressive symptoms at average doses of 150 mg/day." | 2.65 | Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients. ( Abrahams, LM; Bremner, JD; Crupie, JE; McCawley, A; Proctor, RC; Sathananthan, GL, 1984) |
| "The nomifensine-treated depressed patients showed significant improvement over the placebo depressed patients early in and throughout treatment." | 2.65 | Nomifensine in geriatric inpatients: a placebo-controlled study. ( Jansen, W; Siegfried, K, 1984) |
| " The findings suggest a more favorable side effect profile for nomifensine, which was associated with a lower frequency of sedating and anticholinergic effects than was seen in the imipramine group." | 2.65 | A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients. ( Feighner, JP; Hendrickson, G; Merideth, CH, 1984) |
| " Side effect information was collected at each visit." | 2.65 | An overview of side effects and long-term experience with nomifensine from United States clinical trials. ( Hardiman, S; Nash, RJ; Yakabow, AL, 1984) |
| "50 patients suffering from endogenous depression were admitted to a double-blind study comparing the efficacy of nomifensine and maprotiline and the side effects associated with treatment." | 2.65 | Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects. ( Levin, A, 1982) |
| " The duration of treatment was 4 weeks and the dosage of both drugs ranged from 50 to 150 mg/day." | 2.65 | A double-blind clinical comparison between nomifensine and amitriptyline in the treatment of endogenous depressions. ( Ayuso Gutierez, JL; López-Ibor Aliño, JJ; Montejo Iglesias, ML; Ramons, JL, 1982) |
| "Nomifensine has demonstrated efficacy in several animal models that have been found to be predictive of clinical antidepressant activity, and has also been found to have a low potential for both cardiovascular and anticholinergic side effects." | 2.37 | Pharmacology of nomifensine: a review of animal studies. ( Fielding, S; Szewczak, MR, 1984) |
| "2." | 1.28 | Effect of nomifensine on platelet monoamine oxidase activity in chronic schizophrenic patients. ( Filinger, EJ, 1989) |
| "Bilaterally olfactory bulbectomized rats were compared with intact rats in their responsiveness to the acute and chronic administration of nomifensine and trazodone in the learned immobility test of Porsolt." | 1.27 | Effect of bilateral olfactory bulbectomy in the rat, alone or in combination with antidepressants, on the learned immobility model of depression. ( Earley, B; Górka, Z; Leonard, BE, 1985) |
| "After four weeks 66% of the endogenous depressions and 53% of the exhaustion depressions had completely regressed." | 1.26 | [Management of treatment-resistant depression without ECT (author's transl)]. ( Adams, C; Gastpar, M; Kielholz, P; Terzani, S, 1981) |
| "Nomifensine was introduced as an effective antidepressant drug with few side effects." | 1.26 | Drug fever due to nomifensine treatment in patients with endogenous depression. ( Lund, NO; Nielsen, JL, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 79 (95.18) | 18.7374 |
| 1990's | 3 (3.61) | 18.2507 |
| 2000's | 1 (1.20) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, J | 1 |
| Kielholz, P | 1 |
| Terzani, S | 1 |
| Gastpar, M | 1 |
| Adams, C | 1 |
| Jellinger, K | 1 |
| Koeppen, D | 1 |
| Rössner, M | 1 |
| Hanks, GW | 1 |
| Leonard, BE | 2 |
| Georgia, EH | 1 |
| Knudsen, P | 1 |
| Bjørndal, N | 1 |
| Johnsen, T | 1 |
| Pfeiffer Petersen, K | 1 |
| Hirsch, SR | 1 |
| Walsh, C | 1 |
| Draper, R | 1 |
| Montgomery, SA | 1 |
| Roy, D | 3 |
| Wynne-Willson, S | 1 |
| Robinson, C | 1 |
| Montgomery, DB | 3 |
| Hamouz, W | 1 |
| Van Dorth, R | 1 |
| Pinder, RM | 1 |
| Stulemeijer, SM | 1 |
| Wistedt, B | 1 |
| Agren, H | 1 |
| Bjaring, B | 1 |
| Källström, B | 1 |
| Lund, M | 1 |
| Månsby, J | 1 |
| Peterson, LE | 1 |
| Roos, BE | 1 |
| Syvälahti, E | 1 |
| Lindberg, R | 1 |
| Iisalo, E | 1 |
| Crook, T | 1 |
| Fielding, S | 1 |
| Szewczak, MR | 1 |
| Feighner, JP | 2 |
| Merideth, CH | 2 |
| Claghorn, JL | 1 |
| Goldstein, BJ | 1 |
| Brauzer, B | 1 |
| Kentsmith, D | 1 |
| Rosenthal, S | 1 |
| Charalampous, KD | 1 |
| Bremner, JD | 1 |
| Abrahams, LM | 1 |
| Crupie, JE | 1 |
| McCawley, A | 1 |
| Proctor, RC | 1 |
| Sathananthan, GL | 1 |
| Fann, WE | 1 |
| Lyle, FA | 1 |
| Higginbotham, W | 1 |
| Jansen, W | 2 |
| Siegfried, K | 3 |
| Cohn, JB | 1 |
| Varga, L | 1 |
| Lyford, A | 1 |
| Hendrickson, G | 1 |
| Gillings, D | 1 |
| Grizzle, J | 1 |
| Koch, G | 1 |
| Rickels, K | 2 |
| Amara, I | 1 |
| Donelan, M | 1 |
| Hardiman, S | 2 |
| Nash, R | 1 |
| Sollecito, W | 1 |
| Stager, W | 1 |
| Overall, JE | 1 |
| Yakabow, AL | 1 |
| Nash, RJ | 1 |
| Quadbeck, H | 1 |
| Lehmann, E | 1 |
| Tegeler, J | 1 |
| Beckmann, H | 2 |
| Holzmüller, B | 2 |
| Fleckenstein, P | 2 |
| Valle-Jones, JC | 1 |
| Craven, JR | 1 |
| Wallis, TD | 1 |
| Schiff, AA | 1 |
| Rettori, V | 1 |
| Rubio, M | 1 |
| Seilicovich, A | 1 |
| Malik, A | 1 |
| de los Santos, A | 1 |
| Kabes, J | 3 |
| Dostal, T | 2 |
| Balon, R | 3 |
| Papezová, H | 2 |
| Pöldinger, W | 1 |
| Streichenwein, SM | 1 |
| Dencker, SJ | 1 |
| Lundin, L | 1 |
| Jensen, K | 1 |
| Klitgaard, NA | 1 |
| Wraae, O | 1 |
| Eggert Hansen, C | 1 |
| Ahlfors, UG | 1 |
| Tuomikoski, S | 1 |
| Pihkanen, T | 1 |
| Jorgensen, HA | 1 |
| Ose, E | 1 |
| Weise, CC | 1 |
| Sandler, K | 1 |
| Schless, A | 1 |
| Zal, M | 1 |
| Norstad, N | 1 |
| Levin, A | 2 |
| López-Ibor Aliño, JJ | 1 |
| Ayuso Gutierez, JL | 1 |
| Montejo Iglesias, ML | 1 |
| Ramons, JL | 1 |
| Shopsin, B | 1 |
| Ong, SB | 1 |
| Lee, CT | 1 |
| Pogády, J | 1 |
| Vencovský, E | 1 |
| Zizka, V | 2 |
| Montogomery, SA | 1 |
| Rani, SJ | 1 |
| Goldstein, SE | 1 |
| Birnbom, F | 1 |
| Laliberte, R | 1 |
| Montgomery, S | 1 |
| Cassano, GB | 2 |
| Conti, L | 2 |
| Dell'Osso, L | 1 |
| Massimetti, G | 2 |
| Scardigli, G | 1 |
| Jans, G | 1 |
| Fornaro, P | 1 |
| Levine, J | 1 |
| Thompson, PJ | 1 |
| Trimble, MR | 2 |
| Laakmann, G | 1 |
| Eckstein, R | 1 |
| Riess, H | 1 |
| Sauer, H | 1 |
| Mempel, W | 1 |
| McIntyre, IM | 1 |
| Burrows, GD | 2 |
| Norman, TR | 2 |
| Dumovic, P | 1 |
| Vohra, J | 1 |
| Nielsen, JL | 1 |
| Lund, NO | 1 |
| Ivanov, V | 1 |
| Popov, G | 1 |
| Brandes, JW | 1 |
| Körst, HA | 1 |
| Littmann, KP | 1 |
| Bech, P | 1 |
| Guelfi, JD | 1 |
| Gelenberg, AJ | 1 |
| Górka, Z | 1 |
| Earley, B | 1 |
| Filinger, EJ | 1 |
| Nolen, WA | 2 |
| Schiwy, W | 1 |
| Heath, WR | 1 |
| Delini-Stula, A | 1 |
| Taneri, Z | 1 |
| Köhler, R | 1 |
| Wang, XJ | 1 |
| Granier, F | 1 |
| Girard, M | 1 |
| Schmitt, L | 1 |
| Boscredon, J | 1 |
| Oules, J | 1 |
| Escande, M | 1 |
| Robertson, MM | 1 |
| Ostrow, D | 1 |
| Pope, HG | 1 |
| Hudson, JI | 1 |
| Cole, JO | 1 |
| van de Putte, JJ | 1 |
| Dijken, WA | 1 |
| Kamp, JS | 1 |
| Blansjaar, BA | 1 |
| Kramer, HJ | 1 |
| Haffmans, J | 1 |
| Harvey, NS | 1 |
| Faltus, F | 1 |
| Filip, V | 1 |
| Karen, P | 1 |
| Kolomazník, M | 1 |
| Korínková, V | 1 |
| Libiger, J | 1 |
| Molcan, J | 1 |
| Zapletálek, M | 1 |
| O'Connolly, M | 2 |
| Mosseri, M | 1 |
| Oppenheim, G | 1 |
| Raz, E | 1 |
| Kahan, K | 1 |
| Guliamov, MG | 1 |
| Funke, HJ | 1 |
| Holtmann, W | 1 |
| Ismail, S | 1 |
| Leonhardt, KF | 1 |
| Muth, H | 1 |
| Omer, LM | 1 |
| Ramm, H | 1 |
| Jarvik, LF | 1 |
| Martlew, VJ | 1 |
| Zankovich, R | 1 |
| Rüthlein, J | 1 |
| Meesmann, M | 1 |
| Gunzer, U | 1 |
| Auer, IO | 1 |
| Schlebusch, L | 1 |
| Dennerstein, L | 1 |
| Davies, BM | 1 |
7 reviews available for nomifensine and Depression, Endogenous
| Article | Year |
|---|---|
Pharmacology of nomifensine: a review of animal studies.
Topics: Acetylcholine; Adenylyl Cyclases; Aggression; Animals; Behavior, Animal; Brain Chemistry; Corpus Str | 1984 |
Four new atypical antidepressants (trazodone, mianserin, nomifensine, caroxazone): results of controlled trials.
Topics: Antidepressive Agents; Benzeneacetamides; Clinical Trials as Topic; Depressive Disorder; Drug Therap | 1982 |
Acute therapy of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Depressive Disorder; Drug Admin | 1993 |
Efficacy of tianeptine in comparative trials versus reference antidepressants. An overview.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Dr | 1992 |
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method | 1986 |
Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality.
Topics: Antidepressive Agents; Clozapine; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Female; | 1986 |
Antidepressant therapy: benefits and risks in perspective.
Topics: Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Depressive Disorder; Dibenzazepines | 1985 |
51 trials available for nomifensine and Depression, Endogenous
| Article | Year |
|---|---|
[Long-term treatment of depressive syndromes with Psyton (author's transl)].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; | 1982 |
Double-blind comparison of the efficacy and safety of nomifensine maleate vs. placebo in depressed outpatients.
Topics: Adolescent; Adult; Ambulatory Care; Child; Clinical Trials as Topic; Depressive Disorder; Drug Erupt | 1984 |
Zimeldine versus nomifensine. A double-blind study of depressed inpatients.
Topics: Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; D | 1984 |
Parasuicide. A review of treatment interventions.
Topics: Adolescent; Adult; Aftercare; Behavior Therapy; Clinical Trials as Topic; Crisis Intervention; Depre | 1982 |
Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Double-Blind Method; Dru | 1983 |
A double-blind trial of mianserin and nomifensine in depressed outpatients.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Double-Blind M | 1983 |
Nomifensine and amitriptyline in the treatment of depression. A multi-centre double-blind comparison.
Topics: Adult; Aged; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fati | 1983 |
Clinical effects and serum levels of nomifensine in depressive patients.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Humans; Isoquinolines; Middle Aged; Nomi | 1983 |
Nomifensine: the preclinical and clinical profile of a second generation antidepressant.
Topics: Aged; Clinical Trials as Topic; Depressive Disorder; Humans; Isoquinolines; Nomifensine | 1984 |
Nomifensine in the depressed elderly patient: discussion.
Topics: Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Humans; Isoqu | 1984 |
Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Double-Blin | 1984 |
Double-blind placebo-controlled multicenter evaluation of the efficacy and safety of nomifensine in depressed outpatients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Capsules; Clinical Trials as Topic; | 1984 |
Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Double-Blin | 1984 |
Nomifensine vs. imipramine in depressed inpatients.
Topics: Adult; Akathisia, Drug-Induced; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; | 1984 |
Nomifensine in geriatric inpatients: a placebo-controlled study.
Topics: Aged; Clinical Trials as Topic; Cognition Disorders; Depressive Disorder; Double-Blind Method; Fatig | 1984 |
A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
Topics: Aged; Akathisia, Drug-Induced; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Doubl | 1984 |
A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
Topics: Aged; Akathisia, Drug-Induced; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Doubl | 1984 |
Pooling 12 nomifensine studies for efficacy generalizability.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder | 1984 |
Efficacy of nomifensine in different depressive syndromes.
Topics: Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Isoqu | 1984 |
An overview of side effects and long-term experience with nomifensine from United States clinical trials.
Topics: Adult; Akathisia, Drug-Induced; Clinical Trials as Topic; Depressive Disorder; Dizziness; Headache; | 1984 |
Comparison of the antidepressant action of tryptophan, tryptophan/5-hydroxytryptophan combination and nomifensine.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination | 1984 |
Clinical investigations into antidepressive mechanisms. II. Dexamethasone suppression test predicts response to nomifensine or amitriptyline.
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Dexamet | 1984 |
Mixed anxiety/depressive illness in general practice. A therapeutic comparison of nomifensine with fluphenazine/nortriptyline.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Drug Combinati | 1983 |
A clinical trial comparing nomifensine and nortriptyline.
Topics: Adolescent; Adult; Age Factors; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; | 1982 |
Nomifensine and imipramine in endogenous depression. A double-blind Scandinavian multicentre study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Human | 1982 |
Nomifensine, imipramine and placebo in depressed outpatients.
Topics: Adult; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; | 1982 |
Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1982 |
A double-blind clinical comparison between nomifensine and amitriptyline in the treatment of endogenous depressions.
Topics: Adult; Age Factors; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind Metho | 1982 |
A double-blind comparison of nomifensine and amitriptyline in the treatment of depression.
Topics: Adult; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Hu | 1981 |
[Clinical experience with treatment of depressions by nomiphenzine (author's transl)].
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Isoquinolines; Male; Middle Ag | 1981 |
[Results of the clinical trial with nomifensine (author's transl)].
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Isoquinolines; Male; Middle Ag | 1981 |
[Mianserin: review and discussion of its double-blind studies versus nomifensine].
Topics: Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Double-Blind Method; Female; Humans; | 1981 |
Nomifensine in the treatment of depressed geriatric patients.
Topics: Adjustment Disorders; Aged; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Bli | 1982 |
Supersensitivity and nomifensine in depressed patients.
Topics: Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine | 1982 |
Four new atypical antidepressants (trazodone, mianserin, nomifensine, caroxazone): results of controlled trials.
Topics: Antidepressive Agents; Benzeneacetamides; Clinical Trials as Topic; Depressive Disorder; Drug Therap | 1982 |
Comparative double-blind study on efficacy and side-effects of trazodone, nomifensine, mianserin in elderly patients.
Topics: Aged; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Double-Blind Method; Female; Hu | 1982 |
A double-blind clinical trial of nomifensine vs. amitriptyline in depressed patients.
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Therapy | 1982 |
Tranylcypromine in depression resistant to cyclic antidepressions.
Topics: 5-Hydroxytryptophan; Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug | 1989 |
Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Mal | 1989 |
Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Flu | 1989 |
[A double-blind comparison study of nomifensine and imipramine in treating depressed patients].
Topics: Adolescent; Adult; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Humans; Im | 1989 |
Depression and anxiety: mianserin and nomifensine compared in a double-blind multicentre trial.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Bipolar Disorder; Depre | 1985 |
The treatment of depression in patients with epilepsy. A double-blind trial.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 1985 |
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; | 1985 |
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method | 1986 |
Where are those new antidepressants we were promised?
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Human | 1988 |
Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relat | 1988 |
[Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
Topics: Adult; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Huma | 1986 |
Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
Topics: Aged; Anthracenes; Antidepressive Agents; Clinical Trials as Topic; Cognition; Depressive Disorder; | 1986 |
Double-blind comparison of diclofensine with nomifensine in outpatients with dysphoric mood.
Topics: Adult; Aged; Depressive Disorder; Female; Humans; Isoquinolines; Male; Middle Aged; Nomifensine | 1986 |
Mianserin is better tolerated and more effective in depression than a nomifensine-clobazam combination: a double-blind study.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Clobazam; Depressi | 1985 |
27 other studies available for nomifensine and Depression, Endogenous
| Article | Year |
|---|---|
The politics and bio-ethics of regulatory trust: case-studies of pharmaceuticals.
Topics: Clinical Trials as Topic; Depressive Disorder; Disclosure; Dopamine Uptake Inhibitors; Drug Industry | 2008 |
[Management of treatment-resistant depression without ECT (author's transl)].
Topics: Antipsychotic Agents; Clomipramine; Depressive Disorder; Female; Humans; Male; Maprotiline; Nomifens | 1981 |
Nomifensine for side-effects of depot neuroleptics.
Topics: Antipsychotic Agents; Depressive Disorder; Humans; Isoquinolines; Nomifensine | 1982 |
Pharmacology of new antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Depressive Disorder; Disease Models, Animal; Dopamine; Humans | 1984 |
Effect of nomifensine on cortisol, prolactin and biogenic amines in neurotic depressed patients.
Topics: Adult; Biogenic Amines; Depressive Disorder; Humans; Hydrocortisone; Isoquinolines; Middle Aged; Nom | 1983 |
[A profile of the clinical effectiveness of second generation antidepressive agents].
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Isoquinolines; Male; Maprotiline; Middle Ag | 1984 |
Dexamethasone suppression test predicts response to nomifensine or amitriptyline.
Topics: Amitriptyline; Depressive Disorder; Dexamethasone; Double-Blind Method; Humans; Isoquinolines; Nomif | 1984 |
Second generation antidepressants.
Topics: Antidepressive Agents, Tricyclic; Catecholamines; Depressive Disorder; Double-Blind Method; Fluoxeti | 1980 |
Non-MAOI antidepressant drugs and cognitive functions: a review.
Topics: Amitriptyline; Antidepressive Agents; Cognition; Cognition Disorders; Depressive Disorder; Dose-Resp | 1982 |
[Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
Topics: Adult; Anthracenes; Clomipramine; Depressive Disorder; Desipramine; Female; Growth Hormone; Humans; | 1980 |
[Nomifensin-induced immune haemolytic anaemias (author's transl)].
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic, Autoimmune; Coombs Test; Depressive Disorder; Humans; | 1981 |
Plasma nomifensine concentration. Cardiological effects and clinical response.
Topics: Adolescent; Adult; Bundle of His; Depressive Disorder; Electrocardiography; Female; Heart; Humans; I | 1980 |
Drug fever due to nomifensine treatment in patients with endogenous depression.
Topics: Aged; Anemia, Hemolytic; Depressive Disorder; Female; Fever; Humans; Isoquinolines; Middle Aged; Nom | 1981 |
[Comparative results of the treatment of anxiety in the depressive syndrome with Tolvon, Vivalan and Alival].
Topics: Aged; Anxiety Disorders; Depressive Disorder; Dibenzazepines; Humans; Isoquinolines; Mianserin; Midd | 1981 |
Do have antidepressants of the second generation anxiolytic properties?
Topics: Adult; Anthracenes; Anxiety; Depressive Disorder; Humans; Isoquinolines; Maprotiline; Middle Aged; M | 1981 |
[Jaundice following nomifensine].
Topics: Chemical and Drug Induced Liver Injury; Cholestasis; Depressive Disorder; Female; Humans; Isoquinoli | 1980 |
Imperfect drugs in an imperfect world.
Topics: Bulimia; Bupropion; Clinical Trials as Topic; Clozapine; Depressive Disorder; Humans; Nomifensine; P | 1992 |
Effect of bilateral olfactory bulbectomy in the rat, alone or in combination with antidepressants, on the learned immobility model of depression.
Topics: Amygdala; Animals; Depressive Disorder; Disease Models, Animal; Humans; Hydroxyindoleacetic Acid; Is | 1985 |
Effect of nomifensine on platelet monoamine oxidase activity in chronic schizophrenic patients.
Topics: Adult; Blood Platelets; Blood Proteins; Depressive Disorder; Humans; Male; Middle Aged; Monoamine Ox | 1989 |
Cognitive symptoms in late-life depression and their treatment.
Topics: Age Factors; Aged; Cognition Disorders; Depressive Disorder; Humans; Nomifensine | 1985 |
Diarrhea and lethal bone marrow depression induced by nomifensine maleate.
Topics: Aged; Bone Marrow Diseases; Depressive Disorder; Diarrhea; Humans; Male; Nomifensine; Pancytopenia | 1987 |
[Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].
Topics: Adjustment Disorders; Adolescent; Adult; Aminoquinolines; Antidepressive Agents; Bipolar Disorder; D | 1986 |
Allergic reactions to nomifensine in the elderly.
Topics: Aged; Depressive Disorder; Drug Hypersensitivity; Humans; Nomifensine | 1986 |
Immune haemolytic anaemia and nomifensine treatment in north west England 1984-85: report of six cases.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antibodies; Depressive Disorder; England; Female; Humans | 1986 |
[Nomifensine side effects and no end?].
Topics: Depressive Disorder; Humans; Nomifensine | 1986 |
[Nomifensine-induced fever with pericardial effusion, basal lung infiltration and pseudo-Pelger-Huet anomaly. A case report].
Topics: Depressive Disorder; Female; Fever; Humans; Middle Aged; Nomifensine; Pelger-Huet Anomaly; Pericardi | 1986 |
Nomifensine (Merital), a new non-tricyclic antidepressant.
Topics: Depressive Disorder; Humans; Isoquinolines; Kinetics; Nomifensine | 1985 |